134 related articles for article (PubMed ID: 6416185)
1. In vitro assessment of combined antibiotic and mucolytic treatment for Pseudomonas aeruginosa infection in cystic fibrosis.
Heaf DP; Webb GJ; Matthew DJ
Arch Dis Child; 1983 Oct; 58(10):824-6. PubMed ID: 6416185
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
[TBL] [Abstract][Full Text] [Related]
3. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
Grenier B; Gilly R
Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
[TBL] [Abstract][Full Text] [Related]
4. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
Michalsen H; Bergan T
Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708
[TBL] [Abstract][Full Text] [Related]
5. Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.
Weller PH; Ingram D; Preece MA; Matthew DJ
Thorax; 1980 Jan; 35(1):42-6. PubMed ID: 6767295
[TBL] [Abstract][Full Text] [Related]
6. Azlocillin in cystic fibrosis.
Malmborg AS; Alfredsson H; Strandvik B
Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
[TBL] [Abstract][Full Text] [Related]
7. Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.
Norden CW; Shaffer MA
Antimicrob Agents Chemother; 1982 Jan; 21(1):62-5. PubMed ID: 6805423
[TBL] [Abstract][Full Text] [Related]
8. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.
Schaad UB; Desgrandchamps D; Kraemer R
Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103
[TBL] [Abstract][Full Text] [Related]
10. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
Penketh A; Hodson ME; Gaya H; Batten JC
Thorax; 1984 Apr; 39(4):299-304. PubMed ID: 6426075
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Møller NE; Høiby N
Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
[TBL] [Abstract][Full Text] [Related]
12. Mistabron in the intensive care unit.
Van De Walle J; Lauwers P; Adriaensen H
Acta Anaesthesiol Belg; 1976; 27 suppl():319-21. PubMed ID: 827913
[TBL] [Abstract][Full Text] [Related]
13. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
Michalsen H; Bergan T
Scand J Infect Dis Suppl; 1981; 29():92-7. PubMed ID: 6947408
[TBL] [Abstract][Full Text] [Related]
14. Anti-pseudomonas activity of azlocillin during pulmonary infection in patients with cystic fibrosis.
Levy J; Baran D; Klastersky J
J Antimicrob Chemother; 1982 Sep; 10(3):235-8. PubMed ID: 6815156
[No Abstract] [Full Text] [Related]
15. Pseudomonas aeruginosa meningitis treated with an azlocillin combination.
Davidson S; Yellin EO; Shaked I; Rubinstein E
Infection; 1982; 10 Suppl 3():S168-9. PubMed ID: 6818154
[TBL] [Abstract][Full Text] [Related]
16. [Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
Vilde JL; Vachon F; Humbert G; Bure A; Bricaire F
Presse Med; 1984 Mar; 13(13):822-4. PubMed ID: 6231604
[TBL] [Abstract][Full Text] [Related]
17. [Monotherapy of Pseudomonas aeruginosa septicemia with azlocillin].
Godard J; Aubertin J; Borderon JC; Dureux JB; Motin J
Presse Med; 1984 Mar; 13(13):819-21. PubMed ID: 6231603
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.
Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K
Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747
[TBL] [Abstract][Full Text] [Related]
19. Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.
McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Taneja A; Murphy P; Goldmann DA
J Infect Dis; 1983 Mar; 147(3):559-67. PubMed ID: 6339649
[TBL] [Abstract][Full Text] [Related]
20. Treatment of serious Pseudomonas infections with azlocillin.
Olive S; Mogabgab WJ; Holmes B; Pollock B; Pauling B; Beville R
J Antimicrob Chemother; 1983 May; 11 Suppl B():153-8. PubMed ID: 6619026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
